Article
Genetically engineered mouse models may be an accurate predictor of how cancer-fighting drugs are delivered to melanoma patients, a new study demonstrates.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.